-
Study finds no causal link between prenatal paracetamol and neurodevelopmental disorders
Medical Mythbusting Commentary for September 25, 2026 Source:Study finds no causal link between prenatal paracetamol and neurodevelopmental disorders Reference:Prenatal exposure to paracetamol and the risk of autism and attention‐deficit/hyperactivity disorder: An umbrella review and meta‐meta‐analysis.
-
Most hair loss associated with GLP1-agonist medications is due to telogen effluvium. It is the rapid weight loss not the drug in this instance that leads to temporary hair loss.
Medical Mythbusting Commentary for September 9, 2026 Source:Could Your GLP-1 Be Making You Bald? One Study Says Maybe Reference:A causal effect of increased GLP1R expression on male-pattern hair loss is suggested by 2-sample Mendelian randomization
-
Mass testosterone screening of healthy male military personnel is not based on clinical evidence or guidelines and is unlikely to change battle readiness or health outcomes.
Medical Mythbusting Commentary for September , 2026 Source:Pentagon issues clinical guidelines on troop testosterone screening to start immediately Reference:The CTV piece is a Reuters write-up of Defense Health Agency clinical guidance issued 2 September 2026. That guidance implements Secretary Hegseth’s 15 July 2026 memo requiring mandatory testosterone-deficiency screening for all active-duty and reserve members aged…
-
An antipsychotic medication quetiapine used off-label as a sleep aid can affect sleep quality and concentration in untreated sleep apnea patients.
Medical Mythbusting Commentary for June 23, 2026 Source:A Commonly Used Sleep Aid May Have a Dangerous Side Effect Reference:Quetiapine modestly improves sleep and breathing but impairs next day performance in people with OSA and difficulty maintaining sleep: A randomized controlled trial
-
Large psilocybin dose briefly improved dementia in case study of an 80 year-old woman. Larger controlled studies are required
Medical Mythbusting Commentary for June 15, 2026 Source:Large psilocybin dose briefly improved dementia in case study Reference:Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration: a case report
-
Explain to parents why Vitamin K administration at birth is a safe and effective means of preventing neonatal bleeding conditions. More parents are saying no to the shot due to misinformation.
Medical Mythbusting Commentary for June 12, 2026 Source:More parents are saying no to newborn vitamin K shots. Experts are concerned. Reference: The following patient handout synthesizes the information discussed across this conversation, covering the rationale for vitamin K at birth, sources of vitamin K, types and symptoms of vitamin K deficiency bleeding, and the outcomes…
-
The mechanism of why statin medications can cause muscles aches has been outlined but this pathway is found in a minority of patients so other reasons remain elusive.
Medical Mythbusting Commentary for June 3, 2026 Source:A Painful Side Effect of Statins Explained After Decades of Mystery Reference:Structural basis for simvastatin-induced skeletal muscle weakness associated with type 1 ryanodine receptor T4709M mutation
-
Beta-blockers, taken by millions after a heart attack, found to be ineffective for people with uncomplicated heart attacks (normal heart function thereafter) and presents increased risk of harm to women. Changes to management likely in the works for this population.
Medical Mythbusting Commentary for May 27, 2026 Source:Common heart drug taken by millions found useless — and possibly dangerous Reference:Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial
-
Science gets closer to understanding how a psychedelic trip changes the brain
Medical Mythbusting Commentary for May 6, 2026 Source:Science gets closer to understanding how a psychedelic trip changes the brain